This application proposes the continuation of the Rush Alzheimer's Disease Core Center (ADCC) with the overall goal of continuing to collect data and specimens that facilitate high-quality scientific studies of Alzheimer's disease and other dementias, both at Rush and at a wide range of other centers. To be maximally effective in this effort, the Rush ADCC must focus on facilitating the types of studies to which it can contribute the most. We propose, therefore, to give special emphasis to assisting studies in five interrelated research areas: i) studies of the transition between normal cognition and Alzheimer's disease, ii) studies with the potential to further the eventual prevention of Alzheimer's disease, iii) studies of prevention of premature institutionalization in Alzheimer's disease, iv) large-scale longitudinal studies, and v) studies with substantial minority participation. The six ADCC cores are designed to achieve these overall goals. The Clinical Core collects data using uniform procedures and emphasizes careful follow-up of defined groups of persons most likely to contribute to the scientific aims of the Center. The Religious Orders Study Core, which began in 1993, follows a group of more than 700 men and women members of Catholic religious communities who have agreed to annual detailed clinical evaluations and to brain donation at death. The Neuropathology Core obtains, processes and evaluates tissue specimens for persons with and without Alzheimer's disease, placing special emphasis on specimens from the Religious Orders Study Core because of their value and the large demand from investigators for this tissue. The Education and Information Transfer Core emphasizes providing information to minorities and enhancing minority access to research and diagnostic and support services. The Data Management and Biostatistics Core, which began in 1995, supplies computer systems for data acquisition and unified data management for all ADCC, cores and biostatistical consultation to both the cores and to investigators using core data.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010161-13
Application #
6616060
Study Section
Special Emphasis Panel (ZAG1-PCR-5 (M1))
Program Officer
Phelps, Creighton H
Project Start
1991-09-30
Project End
2006-06-30
Budget Start
2003-07-15
Budget End
2004-06-30
Support Year
13
Fiscal Year
2003
Total Cost
$1,811,357
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Kovaleva, Mariya A; Bilsborough, Elizabeth; Griffiths, Patricia C et al. (2018) Testing Tele-Savvy: Protocol for a randomized controlled trial. Res Nurs Health 41:107-120
Mahady, L; Nadeem, M; Malek-Ahmadi, M et al. (2018) HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease. Neuropathol Appl Neurobiol :
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Sekiya, Michiko; Wang, Minghui; Fujisaki, Naoki et al. (2018) Integrated biology approach reveals molecular and pathological interactions among Alzheimer's A?42, Tau, TREM2, and TYROBP in Drosophila models. Genome Med 10:26
Kommaddi, Reddy Peera; Das, Debajyoti; Karunakaran, Smitha et al. (2018) A? mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease. J Neurosci 38:1085-1099
Mahady, Laura; Nadeem, Muhammad; Malek-Ahmadi, Michael et al. (2018) Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer's Disease. J Alzheimers Dis 62:115-131
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Boyle, Patricia A; Yu, Lei; Wilson, Robert S et al. (2018) Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol 83:74-83
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Wang, Dai; Schultz, Tim; Novak, Gerald P et al. (2018) Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. J Alzheimers Dis 62:855-865

Showing the most recent 10 out of 786 publications